Boonen A - Search Results

1

Robustness and generalizability of smallest detectable difference in radiological progression.

Lassere MN, van der Heijde D, Johnson K, Bruynesteyn K, Molenaar E, Boonen A, Verhoeven A, Emery P, Boers M. Lassere MN, et al. Among authors: boonen a. J Rheumatol. 2001 Apr;28(4):911-3. J Rheumatol. 2001. PMID: 11327275

2

Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.

Bruynesteyn K, van der Heijde D, Boers M, Lassere M, Boonen A, Edmonds J, Houben H, Paulus H, Peloso P, Saudan A, van der Linden S. Bruynesteyn K, et al. Among authors: boonen a. J Rheumatol. 2001 Apr;28(4):904-10. J Rheumatol. 2001. PMID: 11327274

3

Smallest detectable difference in radiological progression.

Lassere M, Boers M, van der Heijde D, Boonen A, Edmonds J, Saudan A, Verhoeven AC. Lassere M, et al. Among authors: boonen a. J Rheumatol. 1999 Mar;26(3):731-9. J Rheumatol. 1999. PMID: 10090192 Clinical Trial.

4

Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials.

van Der Heijde D, Boonen A, Boers M, Kostense P, van Der Linden S. van Der Heijde D, et al. Among authors: boonen a. Rheumatology (Oxford). 1999 Dec;38(12):1213-20. doi: 10.1093/rheumatology/38.12.1213. Rheumatology (Oxford). 1999. PMID: 10587548

5

The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials.

Ortiz Z, Shea B, Garcia Dieguez M, Boers M, Tugwell P, Boonen A, Wells G. Ortiz Z, et al. Among authors: boonen a. J Rheumatol. 1999 Jan;26(1):210-6. J Rheumatol. 1999. PMID: 9918266 Review.

6

Muhammad Asim Khan. Portrait of a rheumatologist as a great artist.

Boonen A, van der Heijde D, van der Linden S. Boonen A, et al. J Rheumatol. 2001 Apr;28(4):843-4. J Rheumatol. 2001. PMID: 11327260 No abstract available.

7

Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review.

Boonen A, de Vet H, van der Heijde D, van der Linden S. Boonen A, et al. J Rheumatol. 2001 May;28(5):1056-62. J Rheumatol. 2001. PMID: 11361189 Review.

8

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, van Zeben D, Dijkmans BA, Peeters AJ, Jacobs P, van den Brink HR, Schouten HJ, van der Heijde DM, Boonen A, van der Linden S. Boers M, et al. Among authors: boonen a. Lancet. 1997 Aug 2;350(9074):309-18. doi: 10.1016/S0140-6736(97)01300-7. Lancet. 1997. PMID: 9251634 Clinical Trial.

9

The ASAS Health Index (ASAS HI) - a new tool to assess the health status of patients with spondyloarthritis.

Kiltz U, van der Heijde D, Boonen A, Braun J. Kiltz U, et al. Among authors: boonen a. Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-105-8. Epub 2014 Oct 30. Clin Exp Rheumatol. 2014. PMID: 25365097 Review.

10

Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study.

Hafström I, Albertsson K, Boonen A, van der Heijde D, Landewé R, Svensson B; BARFOT Study Group. Hafström I, et al. Among authors: boonen a. Ann Rheum Dis. 2009 Apr;68(4):508-13. doi: 10.1136/ard.2008.087833. Epub 2008 Apr 17. Ann Rheum Dis. 2009. PMID: 18420939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters